StonvexLoading…
StonvexStonvexStonvexCore line items from ZBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.23B | $7.68B | $7.39B | $6.94B |
Operating Income | $1.10B | $1.29B | $1.28B | $696.30M |
Net Income | $705.10M | $903.80M | $1.02B | $231.40M |
EPS (Diluted) | $3.55 | $4.43 | $4.88 | $1.10 |
Total Assets | $23.09B | $21.37B | $21.50B | $21.07B |
Total Liabilities | $10.39B | $8.89B | $9.01B | $9.04B |
Cash & Equivalents | $591.90M | $525.50M | $415.80M | $375.70M |
Free Cash Flow OCF − CapEx | $1.47B | $1.30B | $1.29B | $1.17B |
Shares Outstanding | 198.70M | 203.90M | 209.70M | 210.30M |